7 Results for "

SOS1-IN-12

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "SOS1-IN-12" in MCE Product Catalog:

Cat. No.: HY-144965
CAS No.: 2654741-56-5
Target:  

SOS1 Ras

Research Areas:  

Cancer

SOS1-IN-12 is a potent son of sevenless homolog 1 (SOS1) inhibitor with a Ki of 0.11 nM for SOS1 and an IC50 of 47 nM for pERK. SOS1-IN-13 can be used for researching anticancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-145926
CAS No.: 2654743-22-1
Purity:  99.75%
Target:  

SOS1 Ras

Research Areas:  

Neurological Disease Cancer

MRTX0902 is a potent, selective, brain-penetrant, and orally active SOS1 inhibitor with a Ki of 1.9 nM. MRTX0902 disrupts the SOS1:KRASG12C protein-protein interaction (PPI). MRTX0902 can be used in research on pancreatic ductal adenocarcinoma .
loading...
    loading...
Cat. No.: HY-144212
CAS No.: 2759387-92-1
Target:  

SOS1 Ras

Research Areas:  

Cancer

SOS1-IN-8 is a potent SOS1 inhibitor with IC50s of 11.6 and 40.7 nM for SOS1-G12D and SOS1-G12V, respectively (WO2022017339A1, compound 2) .
loading...
    loading...
Cat. No.: HY-144210
CAS No.: 2751718-88-2
Target:  

SOS1 Ras

Research Areas:  

Cancer

SOS1-IN-6 (compound 33-P1) is a potent SOS1 inhibitor with IC50s of 14.9 and 73.3 nM for SOS1-G12D and SOS1-G12V, respectively .
loading...
    loading...
Cat. No.: HY-178044
Target:  

SOS1

Research Areas:  

Cancer

SOS1-IN-24 (Compound 15) is a SOS1 inhibitor with an IC50 of 0.398  μM. SOS1-IN-24 effectively disrupts SOS1::KRAS12D interaction. SOS1-IN-24 can be used for cancers like pancreatic and colorectal cancer research .
loading...
    loading...
Cat. No.: HY-144211
CAS No.: 2755415-30-4
Target:  

SOS1 Ras

Research Areas:  

Cancer

SOS1-IN-7 (compound 18-p1) is a potent SOS1 inhibitor with IC50s of 20 and 67 nM for SOS1-G12D and SOS1-G12V, respectively .
loading...
    loading...
Cat. No.: HY-168716
Target:  

SOS1 Ras

Research Areas:  

Cancer

SOS1-IN-17 (Compound 8d) is an orally active inhibitor for SOS1-KRASG12C interaction with an IC50 of 5.1 nM. SOS1-IN-17 inhibits ERK phosphorylation in DLD-1 cell with an IC50 of 18 nM. SOS1-IN-17 exhibits anti-proliferative activity in KRASG12C mutated Mia-Paca-2 cell with an IC50 of 0.11 μM. SOS1-IN-17 exhibits antitumor efficacy against pancreatic cancer in mouse model .
loading...
    loading...